Can a higher dose of aspirin prevent a dangerous pregnancy complication?

NCT ID NCT07373756

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a higher dose of aspirin (150mg) is better than the usual dose (75mg) at preventing preeclampsia, a serious condition involving high blood pressure during pregnancy. The trial will include 86 pregnant women in Kathmandu who are at high risk based on a scoring system. Participants will take aspirin daily from enrollment until delivery, and doctors will monitor for signs of preeclampsia.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Aspirin

What this could lead to

If successful, this could show that a higher dose of aspirin (150mg) is more effective than the standard 75mg at preventing preeclampsia in high-risk pregnancies.

What could go wrong

This is a small, single-center trial (86 participants) that hasn't started recruiting yet. Results may not apply to all populations, and aspirin carries risks like bleeding or allergic reactions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREGNANCY INDUCED HYPERTENSION (PIH) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertension, pregnancy-induced hypertensive disorder preeclampsia prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.